STOCK TITAN

Scansource Inc 8-K Filings

SCSC NASDAQ

Every 8-K that Scansource Inc (SCSC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow SCSC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SCSC filings page.

Rhea-AI Summary

SCANSOURCE, INC. (symbol: SCSC) is the issuer of record for a Form 8-K filing submitted to the SEC.

Rhea-AI Summary

ScanSource, Inc. (SCSC) reported strong results for the quarter and fiscal year ended June 30, 2026 and announced a definitive agreement to acquire MicroAge. For Q4 FY26, net sales were $953.1 million, up 17.3% year-over-year, with GAAP net income of $25.6 million and diluted EPS of $1.24, up 40.9%. Q4 non-GAAP diluted EPS was $1.46, up 43.1%, and adjusted EBITDA rose to $46.1 million (4.84% margin). Full-year FY26 net sales reached $3.23 billion, up 6.1%, with GAAP diluted EPS of $3.64 (up 21.3%) and non-GAAP diluted EPS of $4.24 (up 18.8%). Adjusted EBITDA for FY26 was $151.5 million, up 4.8%.

ScanSource generated FY26 operating cash flow of $123.1 million and free cash flow of $113.8 million, repurchasing $97.9 million of stock and ending June 30, 2026 with cash of $88.4 million and total debt of $101.4 million (net debt about $13.0 million). The company agreed to acquire MicroAge for $220.5 million in cash, funded via its credit facility; the deal is expected to be accretive to gross margin, adjusted EBITDA margin, and non-GAAP EPS and to close in the quarter ending September 30, 2026, subject to customary conditions. For FY27, excluding MicroAge, ScanSource guides to net sales growth of 6%–10%, adjusted EBITDA of $158–$165 million, and free cash flow of at least $85 million.

Rhea-AI Summary

ScanSource, Inc. reported that Peter C. Browning, a director since 2014 and former Lead Independent Director, retired from its Board of Directors effective August 12, 2026. The company states that this transition is not due to any disagreement between Browning and ScanSource. Following his retirement, the Board size decreased to seven members.

The company highlights Browning’s prior service as Lead Independent Director from February 2019 to January 2026 and includes statements from Browning, Chair and CEO Mike Baur, and current Lead Independent Director Charlie Mathis recognizing his leadership and governance contributions. ScanSource reiterates its role as a technology distributor serving channel sales partners across hardware, SaaS, connectivity and cloud services.

Rhea-AI Summary

ScanSource, Inc. reported a leadership change involving its technology function. On May 22, 2026, the company notified Senior Executive Vice President and Chief Information Officer Rachel Hayden that her role will be eliminated, effective June 8, 2026.

Under the company’s Executive Severance Plan, she will receive severance benefits and will be bound by non-compete, non-solicitation, non-disclosure and other restrictive covenants described in that plan.

Rhea-AI Summary

ScanSource, Inc. reported higher third-quarter fiscal 2026 revenue and solid cash generation while raising its full-year free cash flow outlook. Net sales for the quarter ended March 31, 2026 rose 8.8% year-over-year to $766.8 million, driven mainly by 9.2% growth in the Specialty Technology Solutions segment. Gross profit increased 6.9% to $107.1 million, with a 14.0% margin.

GAAP net income was $16.9 million and diluted EPS was $0.78, up from $0.74 a year earlier. Non-GAAP diluted EPS increased to $0.94. Adjusted EBITDA was $35.6 million, or 4.65% of net sales. Year-to-date operating cash flow reached $125.4 million and free cash flow $118.6 million. The company reaffirmed fiscal 2026 net sales guidance of $3.0–$3.1 billion and adjusted EBITDA of $140–$150 million, and raised its non-GAAP free cash flow outlook from at least $80 million to at least $90 million. As of March 31, 2026, ScanSource held $120.3 million in cash and cash equivalents and $102.0 million of total debt, resulting in net cash and a trailing twelve-month adjusted EBITDA of $144.0 million.

Rhea-AI Summary

ScanSource, Inc. reported leadership changes in its senior management team. Effective March 16, 2026, Alexandre Conde, currently Senior Executive Vice President and Chief People Officer, will shift roles to become Senior Executive Vice President, Strategy. On March 6, 2026, the company hired Michael Webb, who will join ScanSource on March 16, 2026 as Senior Executive Vice President, Chief Human Resources Officer. These moves realign executive responsibilities around strategy and human resources while keeping Conde in a key leadership role focused on strategic initiatives.

Rhea-AI Summary

ScanSource, Inc. furnished an update on its recent financial and governance developments. The company issued a press release announcing financial results for its second quarter ended December 31, 2025, along with an unaudited earnings infographic, both of which are available as exhibits and on its website.

The filing also details Board leadership changes. Charles A. Mathis has been appointed Lead Independent Director and Chair of the Nominating and Corporate Governance Committee, succeeding Peter C. Browning, who remains on the Board and all its committees. Vernon J. Nagel succeeds Mr. Mathis as Chair of the Audit Committee.

Rhea-AI Summary

ScanSource, Inc. filed an 8-K/A confirming a planned change in independent auditors. The Audit Committee approved the transition after a competitive process on October 9, 2025. Grant Thornton LLP was dismissed effective November 6, 2025, immediately after the company filed its Form 10-Q for the quarter ended September 30, 2025. Deloitte & Touche LLP’s engagement began November 6, 2025 for the fiscal year ending June 30, 2026 and related interim periods commencing after September 30, 2025.

Grant Thornton’s audit reports for the fiscal years ended June 30, 2025 and June 30, 2024 contained no adverse opinion, disclaimer, or qualification as to uncertainty, audit scope, or accounting principles. The company reports no disagreements or reportable events with Grant Thornton through November 6, 2025. Grant Thornton’s concurrence letter is filed as Exhibit 16.1.

Rhea-AI Summary

ScanSource, Inc. furnished an update on its first-quarter results for the period ended September 30, 2025. The company issued a press release and an earnings infographic, which are provided as Exhibits 99.1 and 99.2 and available on its website.

The materials are unaudited and are being furnished, not filed, under the Exchange Act. ScanSource also noted that an updated investor presentation will be posted on its website within approximately two weeks.

Rhea-AI Summary

ScanSource, Inc. announced an auditor transition. Following a competitive process, the Audit Committee approved the dismissal of Grant Thornton LLP as independent registered public accounting firm, effective upon completion of the interim review of the Form 10-Q for the three months ended September 30, 2025. Grant Thornton was notified on October 10, 2025.

The Committee appointed Deloitte & Touche LLP as the new independent auditor for the fiscal year ending June 30, 2026 and related interim periods commencing after September 30, 2025, subject to completion of standard client acceptance procedures and an engagement letter. ScanSource reports that Grant Thornton’s audit opinions for fiscal 2024 and 2025 were unmodified and there were no disagreements or reportable events through October 9, 2025. Grant Thornton’s concurrence letter, dated October 16, 2025, is filed as Exhibit 16.1.

Rhea-AI Summary

ScanSource, Inc. filed a current report to furnish its financial results for the fourth quarter and fiscal year ended June 30, 2025. On August 21, 2025, the company issued a press release and an accompanying earnings infographic outlining these results, which are attached as Exhibits 99.1 and 99.2 and made available on its website.

The exhibits are described as unaudited and intended to be read together with ScanSource’s annual and quarterly reports filed with the SEC. The company also plans to post an updated investor presentation on its website within approximately two weeks of the results announcement.